ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628297 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628297; 2) Community: the network communities that were significantly associated with the response to NSC 628297; 3) Molecule: the relationships between components within communities and NSC 628297; 4) MDR: the compounds that were significantly associated with the NSC 628297.

NSC Compound Enrichment Correlation
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0339770934764509 0.34335197
NSC 763587 Null 0.0339770934764509 0.26105538
NSC 697678 Null 0.0339770934764511 0.0679417
NSC 13479 Null 0.0339770934764513 0.20322552
NSC 174121 Methotrexate Derivative 0.0339770934764513 0.21595635
NSC 191924 Null 0.0339770934764513 0.26393289
NSC 30637 Null 0.0339770934764513 0.21998256
NSC 317917 1-Propanone, 3-(dimethylamino)-2-[(dimethylamino)methyl]-1-(4-methoxyphenyl)-, dihydrochloride 0.0339770934764513 0.27535552
NSC 376266 1-Piperazinethiocarboxylic acid, 4-(2-propynyl)- 2-[1-(2-pyridinyl)ethylidene]hydrazide 0.0339770934764513 0.35945875
NSC 38535 2,6-Bis(4-morpholinylmethyl)cyclohexanone,dihydrochloride 0.0339770934764513 0.18341983
Total:126  Current:83    [First] [Prev] [Next] [Last]